Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Antonio Rueda-Ramos"'
Autor:
Jesús Machuca-Aguado, Antonio Félix Conde-Martín, Alejandro Alvarez-Muñoz, Enrique Rodríguez-Zarco, Alfredo Polo-Velasco, Antonio Rueda-Ramos, Rosa Rendón-García, Juan José Ríos-Martin, Miguel A. Idoate
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 22, p 16060 (2023)
The prognostic and predictive role of tumor-infiltrating lymphocytes (TILs) has been demonstrated in various neoplasms. The few publications that have addressed this topic in high-grade serous ovarian carcinoma (HGSOC) have approached TIL quantificat
Externí odkaz:
https://doaj.org/article/ec6e089434f94725a6be716915d6f202
Autor:
Beatriz Mora Rodríguez, María Carmen Martínez Díaz, Juan Francisco Marín Pozo, Begoña Muros de Fuentes, Paz Quesada Sanz, Fátima Artime Rodríguez-Hermida, María José Martínez Bautista, Úrsula Baños Roldán, José Carlos Roldán Morales, Patricia Rodríguez Gómez, María Teresa Garrido Martínez, Ana I. Sánchez, Juan Manuel Duarte Pérez, Macarena Merino Almazán, Rosa Villatoro Roldán, Antonio Rueda Ramos, Ángel Inoriza Rueda, José Miguel García, Margarita Garrido Siles, Pablo Nieto Guindo, Ana Laura Ortega Granados, Silvia Maria Artacho Criado
Publikováno v:
International Journal of Clinical Pharmacy. 41:272-279
Background Immunotherapy has become a standard treatment for lung cancer; however, the high cost makes it necessary to assess health outcomes. Objective The aim of this study was to evaluate the effectiveness, safety and economic cost of nivolumab in
Autor:
Petra Rosado-Varela, Macarena González-Guerrero, Patricia Ramírez-Daffós, Inmaculada Expósito-Álvarez, Esperanza Arriola-Arellano, Cristina Cortés-Carmona, E. Benítez-Rodríguez, María C. Díaz-Blanco, Antonio Rueda-Ramos, José Manuel Baena-Cañada, Lourdes Solana-Grimaldi, Sara Estalella-Mendoza
Publikováno v:
European Journal of Cancer. 48:3328-3334
Aim of the study The authors analyse the effect of chemotherapy on the use of additional health-care resources and report the clinical and demographic factors associated with such use. Patients and methods In women with breast cancer, eligible to rec
Autor:
Encarnación Benítez, Antonio García-Curiel, José M. Baena-Cañada, Antonio Rueda-Ramos, Francisca Partida-Palma, María J. Palomo-González
Publikováno v:
Medicina Clínica. 125:601-605
Fundamento y objetivo Se evalua la utilidad de la gammagrafia mamaria con tecnecio 99m-sestamibi para determinar la respuesta a la quimioterapia neoadyuvante en el cancer de mama. Pacientes y metodo En 50 pacientes consecutivas con carcinoma de mama,
Autor:
José M, Baena-Cañada, Francisca, Partida-Palma, María J, Palomo-González, Encarnación, Benítez, Antonio, Rueda-Ramos, Antonio, García-Curiel
Publikováno v:
Medicina clinica. 125(16)
We sought to evaluate the usefulness of Tc-99m-sestamibi breast scintigraphy in predicting neoadjuvant chemotherapy response in patients with breast cancer.In 50 consecutive patients with breast cancer stages II and III, physical examination, mammogr